SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-10-003180
Filing Date
2010-08-13
Accepted
2010-08-13 12:13:08
Documents
5
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0610_soligenix.htm 10-Q 698364
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF SARBANES-OXL f10q0610ex31i_soligenix.htm EX-31.1 15869
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF SARBANES-OXL f10q0610ex31ii_soligenix.htm EX-31.2 15717
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF SARBANES-OXL f10q0610ex32i_soligenix.htm EX-32.1 6642
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 OF SARBANES-OXL f10q0610ex32ii_soligenix.htm EX-32.2 6193
  Complete submission text file 0001213900-10-003180.txt   744529
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16929 | Film No.: 101013955
SIC: 2834 Pharmaceutical Preparations